Before using, please read over the Canada Vigilance Adverse Reaction caveat document.

This is a proof-of-concept product, showing analysis for new active substances approved in Canada since 2016-01-01

This is a prototype experiment that utilizes publically available data from Canada Vigilance Adverse Reaction Online Database and OpenFDA API providing visualizations in an interactive format.This app allows users to effortlessly interact with the reports database, conduct searches and view results in highly interactive dashboards.

For more detailed analysis, please refer to other Apps developed by the Data Science group